F857-0310 Screening compound: 1-[(1-isopropyl-1H-1,2,3-benzotriazol-5-yl)sulfonyl]-N-(3-morpholinopropyl)-2-pyrrolidinecarboxamide

F857-0310 Screening compound: 1-[(1-isopropyl-1H-1,2,3-benzotriazol-5-yl)sulfonyl]-N-(3-morpholinopropyl)-2-pyrrolidinecarboxamide
F857-0310 Screening compound: 1-[(1-isopropyl-1H-1,2,3-benzotriazol-5-yl)sulfonyl]-N-(3-morpholinopropyl)-2-pyrrolidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F857-0310
1-[(1-isopropyl-1H-1,2,3-benzotriazol-5-yl)sulfonyl]-N-(3-morpholinopropyl)-2-pyrrolidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F857-0310

Molecular Formula

C21H32N6O4S (C21 H32 N6 O4 S)

Compound Name

1-[(1-isopropyl-1H-1,2,3-benzotriazol-5-yl)sulfonyl]-N-(3-morpholinopropyl)-2-pyrrolidinecarboxamide

IUPAC name

N-[3-(morpholin-4-yl)propyl]-1-{[1-(propan-2-yl)-1H-123-benzotriazol-5-yl]sulfonyl}pyrrolidine-2-carboxamide

SMILES

CC(C)n1nnc2c1ccc(S(N(CCC1)C1C(NCCCN1CCOCC1)=O)(=O)=O)c2

InChI

InChI=1S/C21H32N6O4S/c1-16(2)27-19-7-6-17(15-18(19)23-24-27)32(29,30)26-10-3-5-20(26)21(28)22-8-4-9-25-11-13-31-14-12-25/h6-7,15-16,20H,3-5,8-14H2,1-2H3,(H,22,28)/t20-/m0/s1

InChI Key

JILMMAHHHMDRQB-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27200151

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.59

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.585

Distribution Coefficient, logD

0.162

Water Solubility, LogSw

-2.42

Polar Surface Area

95.098

Acid Dissociation Constant (pKa)

14.38

Base Dissociation Constant (pKb)

7.62

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

66.67

F857-0310 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Anti-HIV1 Library (19540 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with F857-0310 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F857-0310?
Check Price and Availability of F857-0310, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F857-0310 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F857-0310
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F857-0310
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F857-0310 available by request